|
|
News Breaks | | | | January 9, 2013 | | 06:30 EDT |  | BMRN | BioMarin not planning to sell itself, even for 25%-30% premium, Reuters reports
BioMariN (BMRN) CEO Jacques Bienaime says the company has been approached by potential suitors but won't sell itself for even a 25%-30% premium, Reuters reports. During an interview at the JP Morgan Healthcare Conference, the executive says that any decision to sell would come from large investors, not him or the board. Reference Link | |
|
News For BMRN From The Last 14 Days Check below for free stories on BMRN the last two weeks. |
|
|
| June 5, 2013 | | 06:06 EDT |  | BMRN | BioMarin initiates Phase 3 trial for phenylketonuria candidate PEG-PAL
 Subscribe for More Information | |
|
|
|
|
|
|
